Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Melasma is common in dark skin individuals and woods light is often not useful in assessing depth of melasma. Approximately 80% of the Indian population present skin color heterogeneity on the face, irrespective of age and gender.

Introduction: Melasma is a common acquired pigmentary skin disorder characterized by a symmetrical macular pigmentation of sun-exposed areas like the face
The three major patterns of pigmentation in melasma are centrofacial (cheeks, forehead, upper lip, and nose), malar (cheeks and nose), and mandibular (mandibular area of cheeks)

Materials / method: Wood’s lamp examination is done to identify the location of pigment but is limited to epidermal melasma and cannot be used reliably in Fitzpatrick skin types V and VI as dark skin melanin pigmentation obscures the detection of dermal melanin.
Wood's lamp examination (340 to 400nm) highlights the difference in pigmentation of the affected skin. Broad spectrum sun screen with SPF of atleast 30, which covers UVA, UVB and visible light. It should be applied liberally (tea spoon rule) every 2-3 hours. Triple combination containing hydroquinone tretinoin and flucinolone acetonide is still first line

Results: 40 women from India treated with serial peels + modified Kligman’s formula (MKF) vs. MKF alone for 5 months. Peel group showed better response in an Indian study.
Tranexamic acid, an anti-fibrinolytic agent, through inhibition of plasminogen activator pathway in skin, is proposed to act by preventing melanocytes activation due to ultraviolet (UV) light, hormones, and injured keratinocyte. Lasers can be used as an adjuvant therapy in resistant cases, provided the selection of patient and counselling has been done properly.

Conclusion: triple combination with chemical peels is preferred first line therapy in Indian patients.
Lasers need to be used carefully in dark skinned patients.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Paradoxical and iatrogenic dyschromias are both complications of long term use of skin lightening products. The clinical manifestations have not been meticulously defined and consensus on proper treatment has not yet been established. The objective of the presentation is to describe the clinical, histopathologic, and dermoscopy findings of exogenous ochronosis in 13 cases, and iatrogenic dyschromia in 8 cases. Treatment modalities and outcomes in all cases will also be shared.

Introduction: Exogenous ochronosis is a paradoxical hyperpigmentation observed in patients who self-medicated with topical hydroquinone for the treatment of melasma. The condition is cosmetically disfiguring and treatment options are presently limited and unsuccessful. The term “iatrogenic dyschromia” has been used to describe the mottled pigmentation observed after long term and repeated exposure to pigment lasers. The clinical characteristics, dermoscopic findings and histopathology resemble the changes seen in poikiloderma of Civatte, however these characterics have not been thoroughly described.

Materials / method: Case series of exogenous ochronosis (13 cases) and iatrogenic dyschromia (8 cases) seen at the Research Institute for Tropical Medicine and a private clinic from March 2007- .December 2022. Clinical manifestations, dermoscopy and histopathogical findings will be described. Different treatment modalities such as topical treatment, mesotherapy, lasers were applied on all patients.

Results: For exogenous ochronosis, male to female ratio is 1:12. All 13 patients used over the counter hydroquinone 2% solutions without sun protection for a mean duration of 5.3 years. Clinically the patients presented with dark brown to black patches on the malar areas (100%). Eight patients presenting with with mottled pigmentation on the forehead, nose and cheeks resembled exogenous ochronosis clinically but histopathology was incompatible. These subset of patients were diagnosed with iatrogenic dyschromia and presents as mottled pigmentation on the face and responds poorly to melasma treatments.

Conclusion: The patients were treated with the Q-switched Nd:YAG, 577 nm , and Er:YAG lasers with promising but variable results. Alternative hydroquinone and arbutin-free skin lightening agents and broad-spectrum sunscreens were prescribed for long-term use.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability